[On the comparative results of the use of Clarisco in peripheral vascular diseases].
D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D002794:Choline / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications; D005492:Folic Acid / Q000627:therapeutic use*; D005734:Gangrene / Q000517:prevention & control; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D013562:Sympathectomy; D013927:Thrombosis / Q000188:drug therapy*; D014652:Vascular Diseases / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009536:Niacinamide; D006493:Heparin; D005492:Folic Acid; D002794:Choline; D014805:Vitamin B 12
Sui risultati comparativi dell'uso del Clarisco nelle vasculopatie periferiche.